Biodexa Pharmaceuticals (BDRX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Biodexa Pharmaceuticals

    NASDAQ: BDRX · Real-Time Price · USD
    6.70
    0.03 (0.45%)
    At close: Oct 03, 2025, 3:59 PM
    6.81
    1.64%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Biodexa Pharmaceuticals Balance Sheet Statement

    Financials in GBP. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.67M 5.97M 2.84M 10.06M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a n/a
    Receivables
    		 715K 704K 329K 33K
    Inventory
    		 n/a -704K n/a n/a
    Other Current Assets
    		 n/a 704K 1.15M 1.06M
    Total Current Assets
    		 8.81M 7.03M 4.69M 11.76M
    Property-Plant & Equipment
    		 324K 571K 831K 1.15M
    Goodwill & Intangibles
    		 5.65M 2.94M 6K n/a
    Total Long-Term Assets
    		 5.97M 3.51M 837K 1.15M
    Total Assets
    		 14.78M 10.54M 5.53M 12.91M
    Account Payables
    		 707K 314K 339K 485K
    Deferred Revenue
    		 1.47M n/a 197K n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 921K 4.23M 386K 664K
    Total Current Liabilities
    		 5.03M 5.57M 1.9M 1.84M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 1.31M n/a n/a -469
    Total Long-Term Liabilities
    		 1.42M 295K 463K 619.53K
    Total Liabilities
    		 6.46M 5.86M 2.36M 2.46M
    Total Debt
    		 727K 464K 624K 766K
    Book Value
    		 8.32M 4.68M 3.16M 10.45M
    Book Value Per Share
    		 134.33 155.93K 3.16M 10.45M
    Common Stock
    		 6.69M 1.19M 108.34K 98.47K
    Retained Earnings
    		 -150.42M -144.77M -135.34M -127.8M
    Comprehensive Income
    		 53M 61.52M 53M 53M
    Shareholders Equity
    		 8.32M 4.68M 3.16M 10.45M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist